ATE181235T1 - Pharmazeutische zusammensetzungen und verfahren unter verwendung von isobutyramid zur behandlung von betaglobinerkrankungen - Google Patents
Pharmazeutische zusammensetzungen und verfahren unter verwendung von isobutyramid zur behandlung von betaglobinerkrankungenInfo
- Publication number
- ATE181235T1 ATE181235T1 AT93907532T AT93907532T ATE181235T1 AT E181235 T1 ATE181235 T1 AT E181235T1 AT 93907532 T AT93907532 T AT 93907532T AT 93907532 T AT93907532 T AT 93907532T AT E181235 T1 ATE181235 T1 AT E181235T1
- Authority
- AT
- Austria
- Prior art keywords
- isobutyramide
- betaglobin
- diseases
- treating
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/852,511 US5439939A (en) | 1992-03-17 | 1992-03-17 | Pharmaceutical compositions and methods using isobutyramide for treating betaglobin disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE181235T1 true ATE181235T1 (de) | 1999-07-15 |
Family
ID=25313524
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93907532T ATE181235T1 (de) | 1992-03-17 | 1993-03-17 | Pharmazeutische zusammensetzungen und verfahren unter verwendung von isobutyramid zur behandlung von betaglobinerkrankungen |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5439939A (de) |
| EP (1) | EP0697862B1 (de) |
| AT (1) | ATE181235T1 (de) |
| AU (1) | AU3810693A (de) |
| DE (1) | DE69325393T2 (de) |
| DK (1) | DK0697862T3 (de) |
| ES (1) | ES2135470T3 (de) |
| GR (1) | GR3031241T3 (de) |
| SG (1) | SG48764A1 (de) |
| WO (1) | WO1993018761A1 (de) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7910624B1 (en) | 1995-03-03 | 2011-03-22 | The Trustees Of Boston University | Compositions for the treatment of blood disorders |
| IT1273628B (it) * | 1993-06-04 | 1997-07-08 | Emerging Pharmaceutical Techno | Composizioni farmaceutiche per la cura della talassemia contenenti derivati dell'acido butirrico e in particolare isobutirramide |
| US5569675A (en) * | 1994-03-07 | 1996-10-29 | Bar Ilan University | Methods of using carboxylic acid esters to increase fetal-hemoglobin levels |
| US5700640A (en) * | 1994-09-16 | 1997-12-23 | Basf Aktiengesellschaft | Inducers of gamma globin gene expression and screening assays therefor |
| US6011000A (en) * | 1995-03-03 | 2000-01-04 | Perrine; Susan P. | Compositions for the treatment of blood disorders |
| US6822267B1 (en) * | 1997-08-20 | 2004-11-23 | Advantest Corporation | Signal transmission circuit, CMOS semiconductor device, and circuit board |
| AU774861B2 (en) | 1998-02-11 | 2004-07-08 | Douglas V Faller | Compositions and methods for the treatment of cystic fibrosis |
| US7154002B1 (en) | 2002-10-08 | 2006-12-26 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
| US7250514B1 (en) | 2002-10-21 | 2007-07-31 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
| FR2847817B1 (fr) * | 2002-11-28 | 2006-11-10 | Centre Nat Rech Scient | Utilisation d'un inhibiteur d'histone deacetylase pour le traitement des dystrophies musculaires |
| EP1608628A2 (de) | 2003-03-17 | 2005-12-28 | Takeda San Diego, Inc. | Inhibitoren der histondeacetylase |
| US20070042937A1 (en) * | 2003-08-01 | 2007-02-22 | Fibrogen, Inc. | Inhibitors of 2-oxoglutarate dioxygenase as gamma globin inducers |
| US7642275B2 (en) | 2004-12-16 | 2010-01-05 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
| EP1896436A2 (de) | 2005-05-11 | 2008-03-12 | Takeda San Diego, Inc. | Inhibitoren der histondeacetylase |
| AU2006270322A1 (en) | 2005-07-14 | 2007-01-25 | Takeda San Diego, Inc. | Histone deacetylase inhibitors |
| US20070185045A1 (en) * | 2006-02-06 | 2007-08-09 | Ratcliffe Peter J | Inhibitors of 2-oxoglutarate dioxygenase as gamma globin inducers |
| US20110086869A1 (en) | 2009-09-24 | 2011-04-14 | The Trustees Of Boston University | Methods for treating viral disorders |
| EP2509418A4 (de) | 2009-12-08 | 2013-03-20 | Hemaquest Pharmaceuticals Inc | Verfahren und niedrigdosierungspläne zur behandlung von erythrozytendysfunktion |
| WO2011113013A2 (en) | 2010-03-11 | 2011-09-15 | Hemaquest Pharmaceuticals, Inc. | Methods and compositions for treating viral or virally-induced conditions |
| US10039813B2 (en) | 2012-02-07 | 2018-08-07 | Massachusetts Institute Of Technology | Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness |
| WO2014144231A1 (en) | 2013-03-15 | 2014-09-18 | Massachusetts Institute Of Technology | Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness |
| WO2016064815A1 (en) * | 2014-10-20 | 2016-04-28 | Massachusetts Institute Of Technology | Functional ghrelin receptor antagonism during pregnancy to prevent stress-associated mental illness in offspring and mothers |
| US10317418B2 (en) | 2015-02-24 | 2019-06-11 | Massachusetts Institute Of Technology | Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness |
| KR20220034736A (ko) | 2019-05-31 | 2022-03-18 | 비락타 서브시디어리 인크. | 히스톤 데아세틸라제 억제제를 사용하여 바이러스 관련 암을 치료하는 방법 |
| AU2022370354A1 (en) | 2021-10-19 | 2024-05-30 | Akirabio, Inc. | Compositions comprising 2'-deoxycytidine analogs and use thereof for the treatment of sickle cell disease, thalassemia, and cancers |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4482571A (en) * | 1982-06-21 | 1984-11-13 | University Of Pittsburgh | Sickle cell anemia treatment and compound |
| US5025029A (en) * | 1986-10-10 | 1991-06-18 | Children's Hospital Medical Center Of Northern California | Method for augmenting fetal hemoglobin |
| US4822821A (en) * | 1986-10-10 | 1989-04-18 | Children's Hospital Medical Center Of Northern California | Method for augmenting fetal hemoglobin |
| SG86966A1 (en) * | 1988-11-29 | 2002-03-19 | Childrens Hosp Medical Center | Medicament for augmenting fetal hemoglobin |
-
1992
- 1992-03-17 US US07/852,511 patent/US5439939A/en not_active Expired - Fee Related
-
1993
- 1993-03-17 ES ES93907532T patent/ES2135470T3/es not_active Expired - Lifetime
- 1993-03-17 AU AU38106/93A patent/AU3810693A/en not_active Abandoned
- 1993-03-17 AT AT93907532T patent/ATE181235T1/de not_active IP Right Cessation
- 1993-03-17 DK DK93907532T patent/DK0697862T3/da active
- 1993-03-17 SG SG1996001424A patent/SG48764A1/en unknown
- 1993-03-17 DE DE69325393T patent/DE69325393T2/de not_active Expired - Fee Related
- 1993-03-17 WO PCT/US1993/002389 patent/WO1993018761A1/en active IP Right Grant
- 1993-03-17 EP EP93907532A patent/EP0697862B1/de not_active Expired - Lifetime
-
1999
- 1999-09-16 GR GR990402332T patent/GR3031241T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69325393D1 (de) | 1999-07-22 |
| EP0697862A1 (de) | 1996-02-28 |
| DK0697862T3 (da) | 1999-12-13 |
| EP0697862B1 (de) | 1999-06-16 |
| GR3031241T3 (en) | 1999-12-31 |
| US5439939A (en) | 1995-08-08 |
| WO1993018761A1 (en) | 1993-09-30 |
| DE69325393T2 (de) | 1999-12-16 |
| EP0697862A4 (de) | 1996-05-29 |
| ES2135470T3 (es) | 1999-11-01 |
| AU3810693A (en) | 1993-10-21 |
| SG48764A1 (en) | 1998-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE181235T1 (de) | Pharmazeutische zusammensetzungen und verfahren unter verwendung von isobutyramid zur behandlung von betaglobinerkrankungen | |
| UA48939C2 (uk) | Дизаміщені фуранони, способи їх одержання, фармацевтична композиція на їх основі, спосіб лікування запального захворювання, проміжні сполуки | |
| BR9502707A (pt) | Composto composição farmacêutica e método para o tratamento de uma afecção | |
| MX9203050A (es) | Compuestos de analogos de triptamina. | |
| ATE192045T1 (de) | Verwendung von substituierten adeninderivaten zur behandlung von multiplesklerose | |
| DE3483629D1 (de) | 2-pyrimidinyl-l-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel. | |
| DE602004002394D1 (de) | (3-ä3-'(2,4-BIS-TRIFLUORMETHYL-BENZYL)-(5-ETHYL-PYRIMIDIN-2-YL)-AMINOÜ-PROPOXYü-PHENYL)-ESSIGSÄURE UND VERWANDTE VERBINDUNGEN ALS MODULATOREN VON PPARS UND VERFAHREN ZUR BEHANDLUNG VON STOFFWECHSELSTÖRUNGEN | |
| DE69413829D1 (de) | Antiglucocorticoidsteroide zur behandlung von angststörungen | |
| DE69125485T2 (de) | Verfahren und zwischenprodukte synthetischer antikörperderivate | |
| ATE225171T1 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
| DE60215649D1 (de) | Zusammensetzungen und verfahren zur behandlung von hyperimmunreaktionen im auge | |
| ATE217191T1 (de) | Verwendung von phanquinon zur behandlung von alzheimer's krankheit | |
| DE69429856D1 (de) | Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit | |
| ATE239470T1 (de) | Melatonin-derivate zur verwendung in der behandlung von desynchronisierungs-erkankungen | |
| ATE151774T1 (de) | Cyclopentanperhydrophenanthren-17-beta-(3-furyl - 3-derivate und pharmazeutische präparate davon, zur behandlung von kardiovaskulär-erkrankungen | |
| ATE417831T1 (de) | Ceramid ähnliche verbindungen, verfahren zu deren herstellung und deren verwendung als antitumormittel | |
| ATE421961T1 (de) | Piperidinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzung zur behandlung von alzheimer-krankheit, die diese derivate enthält | |
| DE69619868D1 (de) | Piperazinylalkylthiopyrimidin derivate, diese enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung | |
| ATE194076T1 (de) | Verwendung von n,s-diacetylcystein-ethylester (dacee) zur herstellung eines medikaments zur behandlung viraler erkrankungen | |
| ATE253889T1 (de) | Mittel und verfahren zur prävention und behandlung von immediaten überempfindlichkeitsreaktionen der haut | |
| DE69424415T2 (de) | Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit | |
| ATE182886T1 (de) | Neue pyridin- bzw. pyridazinderivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel | |
| ATE184287T1 (de) | Derivate von therapeutisch in der blutgerinnungskaskade wirksamen peptiden, verfahren zur herstellung und sie enthaltende pharmazeutische zubereitungen | |
| DE60041266D1 (de) | Zusammensetzung und verfahren zur behandlung von immunverwandten krankheiten | |
| ATE242766T1 (de) | Neue derivate von benzoylalkyl-1,2,3,6- tetrahydropyridinen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |